Delivra Health Brands (FRA:3F0) Moat Score: 2/10 (As of Jul. 05, 2026)


FRA:3F0 Delivra Health Brands Inc FRA:3F0
28 GF Score
Price €0.04
GF Value €0.09
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Delivra Health Brands Moat Score?

Delivra Health Brands FRA:3F0 -1.19% 28 Moat Score is 2 as of Jul. 05, 2026. GuruFocus rates FRA:3F0 with a GF Score™ of 28/100 and a GF Value™ of €0.09 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 1,030 Drug Manufacturers companies, Delivra Health Brands ranks better than 81.65% on this metric.

Delivra Health Brands has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Delivra Health Brands has No Moat: Delivra Health Brands operates in a highly competitive market with limited brand strength and no significant intellectual property or cost advantages. The company lacks substantial market leadership or customer loyalty, resulting in very weak competitive advantages.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Delivra Health Brands might have No Moat - Very weak/transient advantages.

Delivra Health Brands  (FRA:3F0) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Delivra Health Brands Moat Score Related Terms

FRA:3F0 vs ZTS, UTHR: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Delivra Health Brands's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Delivra Health Brands Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Delivra Health Brands's Moat Score distribution charts can be found below:

* The bar in red indicates where Delivra Health Brands's Moat Score falls into.


FRA:3F0
28GF Score
Delivra Health Brands Inc FRA:3F0
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Delivra Health Brands (FRA:3F0) has a Moat Score of 2 as of Jul. 05, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Delivra Health Brands ranks #189 out of 1030 companies in the Drug Manufacturers industry, placing it in the top 18.3%.
Is Delivra Health Brands' Moat Score too high?
Delivra Health Brands' current Moat Score is 2. Based on the distribution chart, Delivra Health Brands ranks #189 out of 1030 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Delivra Health Brands has a GF Score™ of 28/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Delivra Health Brands' Moat Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Delivra Health Brands ranks #189 out of 1030 companies for Moat Score. This places Delivra Health Brands in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Delivra Health Brands's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delivra Health Brands stock overvalued right now?
Based on GuruFocus' analysis, Delivra Health Brands (FRA:3F0) is currently considered Possible Value Trap. The stock's GF Value™ is €0.09, compared to a current price of €0.04 — trading 53.9% below its estimated fair value. The current Moat Score is 2. Delivra Health Brands' overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Delivra Health Brands (FRA:3F0), the current Moat Score is 2 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Delivra Health Brands (FRA:3F0) Overvalued in 2026?

Based on GuruFocus' analysis, Delivra Health Brands stock appears to be undervalued. The current stock price of €0.04 is trading 53.9% below its estimated GF Value™ of €0.09. GuruFocus considers Delivra Health Brands to be Possible Value Trap.

Key valuation signals for FRA:3F0:

  • Moat Score: 2
  • GF Value™: €0.09 vs. price of €0.04 (53.9% below fair value)
  • GF Score™: 28/100 with 3 warning signs

No single metric tells the full story. See the FRA:3F0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Delivra Health Brands Business Description

Address 999 Canada Place, Suite 404, Vancouver, BC, CAN, V6C 3E2
Delivra Health Brands Inc helping people take control of health with alternative wellness solutions. Its portfolio features brands like Dream Water and LivRelief that deliver relief from common, everyday issues like chronic pain, anxiety, and sleeplessness. The principal activities of the company are to provide lifestyle and health and wellness products to consumers and patients in regulated markets. The company geographically operates in Canada and United States, out of which it generates maximum revenue from Unites States.
28GF Score

Get the complete analysis for FRA:3F0

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.04
Price
€0.09
GF Value